Clindamycin resistance in Bacteroides fragilis.

Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J Bacteriol (1986) 2.69

Sequence homology of clindamycin resistance determinants in clinical isolates of Bacteroides spp. Antimicrob Agents Chemother (1983) 1.67

Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy. Antimicrob Agents Chemother (1986) 0.89

Modified broth-disk surveillance of clindamycin-resistant Bacteroides fragilis group. Antimicrob Agents Chemother (1983) 0.81

Inducible expression of ribosomal clindamycin resistance in Bacteroides vulgatus. Antimicrob Agents Chemother (1992) 0.75

Rapid detection of clindamycin resistance in Bacteroides spp. J Clin Microbiol (1983) 0.75

Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86

In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76

In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01

Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother (1990) 5.24

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother (1999) 4.44

Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II. J Bacteriol (1990) 4.24

Inorganic phosphate transport in Escherichia coli: involvement of two genes which play a role in alkaline phosphatase regulation. J Bacteriol (1973) 4.16

Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1976) 4.07

In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother (1980) 3.90

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 3.87

Electron microscopy of polar insertions in the lac operon of Escherichia coli. Mol Gen Genet (1972) 3.85

Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83

Frameshift mutations in the lactose operon of E. coli. Cold Spring Harb Symp Quant Biol (1966) 3.83

Management of anaerobic infections. Ann Intern Med (1975) 3.62

Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med (1972) 3.62

Polar mutations in lac, gal and phage lambda consist of a few IS-DNA sequences inserted with either orientation. Mol Gen Genet (1972) 3.59

T7 translational control mechanisms and their inhibiton by F factors. Nat New Biol (1971) 3.17

Bacteroides fragilis resistant to the administration of clindamycin. Am J Med (1976) 3.13

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother (1993) 3.13

Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis. J Bacteriol (1982) 2.80

Oxygen tolerance of fresh clinical anaerobic bacteria. J Clin Microbiol (1975) 2.77

Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother (1979) 2.75

Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71

Inducible plasmid-determined resistance to arsenate, arsenite, and antimony (III) in escherichia coli and Staphylococcus aureus. J Bacteriol (1981) 2.70

In vitro activity of azthreonam, a monobactam antibiotic. Antimicrob Agents Chemother (1982) 2.70

Cefoxitin inactivation by Bacteroides fragilis. Antimicrob Agents Chemother (1983) 2.64

Control of the synthesis of alkaline phosphatase and the phosphate-binding protein in Escherichia coli. J Bacteriol (1976) 2.48

Tn4400, a compound transposon isolated from Bacteroides fragilis, functions in Escherichia coli. J Bacteriol (1985) 2.48

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47

Mechanisms of drug-resistance transfer in Bacteroides fragilis. J Antimicrob Chemother (1981) 2.46

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45

Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis (1979) 2.38

Characterization of two genetically separable inorganic phosphate transport systems in Escherichia coli. J Bacteriol (1980) 2.27

Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother (1976) 2.26

A new insertion sequence, IS121, is found on the Mu dI1 (Ap lac) bacteriophage and the Escherichia coli K-12 chromosome. J Bacteriol (1983) 2.25

Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother (1987) 2.25

Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother (1975) 2.21

Once-daily dosing in dogs optimizes daptomycin safety. Antimicrob Agents Chemother (2000) 2.00

Arsenate resistant mutants of Escherichia coli and phosphate transport. Biochem Biophys Res Commun (1970) 1.98

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95

Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy. Rev Infect Dis (1984) 1.94

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J Med Chem (1994) 1.93

Evidence for the presence of nontranslated T7 late mRNA in infected F'(PIF+) episome-containing cells. J Virol (1974) 1.89

Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob Agents Chemother (2000) 1.84

F factor mobilization of non-conjugative chimeric plasmids in Escherichia coli: general mechanisms and a role for site-specific recA-independent recombination at orV1. J Mol Biol (1980) 1.80

Hybridization studies reveal homologies between pBF4 and pBFTM10, Two clindamycin-erythromycin resistance transfer plasmids of Bacteroides fragilis. J Bacteriol (1982) 1.79

Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med (1976) 1.73

Antimicrobial resistance in anaerobes. Clin Infect Dis (1997) 1.73

Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69

Superoxide dismutase in anaerobic bacteria of clinical significance. Infect Immun (1977) 1.68

Sequence homology of clindamycin resistance determinants in clinical isolates of Bacteroides spp. Antimicrob Agents Chemother (1983) 1.67

Tn4399, a conjugal mobilizing transposon of Bacteroides fragilis. J Bacteriol (1989) 1.66

Candida infections in surgical patients. Ann Surg (1983) 1.63

Escherichia coli chromosomal mutations that permit direct cloning of the Bacteroides fragilis metallo-beta-lactamase gene, ccrA. Mol Microbiol (1991) 1.59

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Antimicrob Agents Chemother (1989) 1.59

Comparisons of F factors and R factors: existence of independent regulation groups in F factors. J Bacteriol (1970) 1.57

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1996) 1.56

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrob Agents Chemother (1991) 1.54

Differentiation of Bacteroides ovatus and Bacteroides thetaiotaomicron by means of bacteriophage. J Clin Microbiol (1984) 1.51

Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother (1987) 1.47

Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis (1974) 1.46

National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. Clin Infect Dis (2002) 1.46

Bacteriology of hospital-acquired pneumonia. Arch Intern Med (1986) 1.45

A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg (1981) 1.45

Characterization of the termini and transposition products of Tn4399, a conjugal mobilizing transposon of Bacteroides fragilis. Proc Natl Acad Sci U S A (1989) 1.41

Susceptibility of Clostridium ramosum to antimicrobial agents. Antimicrob Agents Chemother (1974) 1.39

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother (1999) 1.38

Effect of arsenate on inorganic phosphate transport in Escherichia coli. J Bacteriol (1980) 1.38

Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob Agents Chemother (1994) 1.36

T7 protein synthesis in F-factor-containing cells: evidence for an episomally induced impairment of translation and relation to an alteration in membrane permeability. J Virol (1975) 1.36

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe (2011) 1.36

Characterization of the Batl (Bacteroides aerotolerance) operon in Bacteroides fragilis: isolation of a B. fragilis mutant with reduced aerotolerance and impaired growth in in vivo model systems. Mol Microbiol (1999) 1.35

Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse. Antimicrob Agents Chemother (1980) 1.34

Inactivation of penicillin G during experimental infection with Bacteroides fragilis. J Infect Dis (1978) 1.34

Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics. Clin Ther (1980) 1.34

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. J Antimicrob Chemother (1990) 1.33

Antimicrobial resistance in Bacteroides. Clin Infect Dis (1993) 1.31

Antimicrobial spectrum of Win 49375. Antimicrob Agents Chemother (1984) 1.31